Bioequivalence Study of Cefprozil Tablets, USP 500 mg Under Fasting Conditions

NCT00778778 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
27
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Ranbaxy Laboratories Limited